Page last updated: 2024-09-02

ecteinascidin 743 and orantinib

ecteinascidin 743 has been researched along with orantinib in 1 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(orantinib)
Trials
(orantinib)
Recent Studies (post-2010) (orantinib)
6601024041101936

Protein Interaction Comparison

ProteinTaxonomyecteinascidin 743 (IC50)orantinib (IC50)
Epidermal growth factor receptorHomo sapiens (human)2.186
Platelet-derived growth factor receptor betaMus musculus (house mouse)3.6
Platelet-derived growth factor receptor betaHomo sapiens (human)1.126
Fibroblast growth factor receptor 1Homo sapiens (human)3.003
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.028
Platelet-derived growth factor receptor alpha Mus musculus (house mouse)3.6
Vascular endothelial growth factor receptor 2Homo sapiens (human)1.8986
Aurora kinase BHomo sapiens (human)0.041
Aurora kinase CHomo sapiens (human)0.21

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1

Other Studies

1 other study(ies) available for ecteinascidin 743 and orantinib

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010